You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
江中藥業(600750.SH):控股子公司通過藥品GMP符合性檢查
格隆匯 12-01 17:35

格隆匯12月1日丨江中藥業(600750.SH)公佈,控股子公司江西南昌濟生製藥有限責任公司收到江西省藥品監督管理局下發的《藥品GMP符合性檢查結果吿知書(2023年第48號)》,濟生製藥新建的中醫藥科創城現代化生產基地相關生產車間、生產線通過藥品GMP符合性檢查。濟生製藥新建的中醫藥科創城現代化生產基地相關生產車間、生產線均為首次通過藥品GMP符合性檢查,表明上述生產基地相關生產車間、生產線滿足藥品GMP要求,將有利於公司繼續保持穩定的產品質量和持續穩定的生產能力,以滿足相關藥品的市場需求。後續,濟生製藥將有序搬遷至中醫藥科創城現代化生產基地。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account